Clinical Trial Update: QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety [Phase 3]

View source ↗

Summary

Phase 3 trial investigating QL1203 in combination with chemotherapy for metastatic colorectal cancer to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• QL1203

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN